ATE207487T1 - Phenyloxazolidinone mit einer c-c-bindung zu 4-8 gliedrigen heterocyclen - Google Patents

Phenyloxazolidinone mit einer c-c-bindung zu 4-8 gliedrigen heterocyclen

Info

Publication number
ATE207487T1
ATE207487T1 AT96927316T AT96927316T ATE207487T1 AT E207487 T1 ATE207487 T1 AT E207487T1 AT 96927316 T AT96927316 T AT 96927316T AT 96927316 T AT96927316 T AT 96927316T AT E207487 T1 ATE207487 T1 AT E207487T1
Authority
AT
Austria
Prior art keywords
alkyl
halo
aryl
methyl
substd
Prior art date
Application number
AT96927316T
Other languages
English (en)
Inventor
Douglas K Hutchinson
Michael D Ennis
Robert L Hoffman
Richard C Thomas
Toni-Jo Poel
Michael Robert Barbachyn
Steven J Brickner
David J Anderson
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=21704418&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE207487(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Upjohn Co filed Critical Upjohn Co
Application granted granted Critical
Publication of ATE207487T1 publication Critical patent/ATE207487T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
AT96927316T 1995-09-01 1996-08-13 Phenyloxazolidinone mit einer c-c-bindung zu 4-8 gliedrigen heterocyclen ATE207487T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US314995P 1995-09-01 1995-09-01
PCT/US1996/012766 WO1997009328A1 (en) 1995-09-01 1996-08-13 Phenyloxazolidinones having a c-c bond to 4-8 membered heterocyclic rings

Publications (1)

Publication Number Publication Date
ATE207487T1 true ATE207487T1 (de) 2001-11-15

Family

ID=21704418

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96927316T ATE207487T1 (de) 1995-09-01 1996-08-13 Phenyloxazolidinone mit einer c-c-bindung zu 4-8 gliedrigen heterocyclen

Country Status (26)

Country Link
US (7) US5968962A (de)
EP (1) EP0856002B1 (de)
JP (1) JPH11512386A (de)
KR (1) KR100463772B1 (de)
CN (1) CN1072222C (de)
AT (1) ATE207487T1 (de)
AU (1) AU716493B2 (de)
BR (1) BR9610474A (de)
CA (1) CA2228647A1 (de)
CZ (1) CZ49398A3 (de)
DE (1) DE69616366T2 (de)
DK (1) DK0856002T3 (de)
ES (1) ES2165516T3 (de)
FI (1) FI980452A0 (de)
HU (1) HUP9901979A3 (de)
MX (1) MX9801578A (de)
NO (1) NO311520B1 (de)
NZ (1) NZ315469A (de)
PL (1) PL186524B1 (de)
PT (1) PT856002E (de)
RU (1) RU2175324C2 (de)
SK (1) SK283487B6 (de)
TW (1) TW419468B (de)
UA (1) UA52620C2 (de)
WO (1) WO1997009328A1 (de)
ZA (1) ZA966935B (de)

Families Citing this family (74)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69616366T2 (de) * 1995-09-01 2002-07-04 Upjohn Co Phenyloxazolidinone mit einer c-c-bindung zu 4-8 gliedrigen heterocyclen
GB9601666D0 (en) * 1996-01-27 1996-03-27 Zeneca Ltd Chemical compounds
GB9702213D0 (en) 1996-02-24 1997-03-26 Zeneca Ltd Chemical compounds
GB9609919D0 (en) * 1996-05-11 1996-07-17 Zeneca Ltd Chemical compounds
FI19992555A7 (fi) * 1997-05-30 1999-11-30 Upjohn Co Antibakteerisia oksatosolidinoniaineita, joilla on tiokarbonyylifunktionaalisuus
CA2294293A1 (en) * 1997-07-11 1999-01-21 Pharmacia & Upjohn Company Thiadiazolyl and oxadiazolyl phenyl oxazolidinone antibacterial agents
GB9717804D0 (en) 1997-08-22 1997-10-29 Zeneca Ltd Chemical compounds
GB9717807D0 (en) * 1997-08-22 1997-10-29 Zeneca Ltd Chemical compounds
GB9725244D0 (en) 1997-11-29 1998-01-28 Zeneca Ltd Chemical compounds
RU2205832C2 (ru) * 1997-12-05 2003-06-10 Фармация Энд Апджон Компани S-оксидо- и s,s-диоксидотетрагидротиопиранфенилоксазолидиноны и способ их тестирования
US6083967A (en) * 1997-12-05 2000-07-04 Pharmacia & Upjohn Company S-oxide and S,S-dioxide tetrahydrothiopyran phenyloxazolidinones
US7002020B1 (en) 1998-01-23 2006-02-21 Pharmacia & Upjohn Company Oxazolidinone combinatorial libraries, compositions and methods of preparation
CA2318969A1 (en) 1998-01-23 1999-07-29 Mikhail F. Gordeev Oxazolidinone combinatorial libraries, compositions and methods of preparation
US6562844B2 (en) 1998-01-23 2003-05-13 Pharmacia & Upjohn Company Oxazolidinone combinatorial libraries, compositions and methods of preparation
EP1082323A2 (de) 1998-06-05 2001-03-14 AstraZeneca UK Limited Oxazolidinon-derivate, verfahren zu ihrer herstellung und diese derivate enthaltende pharmazeutische zusammensetzungen
GB9812019D0 (en) * 1998-06-05 1998-07-29 Zeneca Ltd Chemical compounds
SI1149089T1 (en) * 1999-02-01 2003-10-31 Pharmacia & Upjohn Company PROCESS TO PREPARE TETRAHYDROTHIOPYRAN-o-FLUORINATED CARBAMATES
ES2194709T3 (es) 1999-02-01 2003-12-01 Upjohn Co Procedimiento para preparar carbamatos de tetrahidrotiopiran-o-fluorados.
MY120189A (en) * 1999-11-04 2005-09-30 Upjohn Co Sultam and sultone derived oxazolidinones
GB9928568D0 (en) 1999-12-03 2000-02-02 Zeneca Ltd Chemical compounds
SK7572002A3 (en) * 1999-12-21 2002-12-03 Upjohn Co Oxazolidinones having a sulfoximine functionality and their use as antimicrobial agents
DE19962924A1 (de) 1999-12-24 2001-07-05 Bayer Ag Substituierte Oxazolidinone und ihre Verwendung
MY127336A (en) 2000-03-22 2006-11-30 Upjohn Co Container for linezolid iv solution
US6514529B2 (en) 2000-03-22 2003-02-04 Pharmacia & Upjohn Company Oxazolidinone tablet formulation
GB0009803D0 (en) * 2000-04-25 2000-06-07 Astrazeneca Ab Chemical compounds
PE20020044A1 (es) 2000-06-16 2002-01-30 Upjohn Co Tiazina oxazolidinona
DE60112581T2 (de) 2000-06-30 2006-06-01 Pharmacia & Upjohn Co. Llc, Kalamazoo Zusammensetzungen zur Behandlung bakterieller Infektionen, welche ein Oxazolidinonderivat, Sulbactam und Ampicillin enthalten
DE60212959T2 (de) * 2001-04-07 2007-02-15 Astrazeneca Ab Eine sulfonimid-gruppe enthaltende oxazolidinone als antibiotika
GB0108764D0 (en) * 2001-04-07 2001-05-30 Astrazeneca Ab Chemical compounds
ATE374463T1 (de) * 2001-04-20 2007-10-15 Pharmacia & Upjohn Co Llc Verfahren zur herstellung von oxazolidinonen
MXPA03009643A (es) 2001-04-20 2004-05-21 Upjohn Co Un metodo para la preparacion de oxazolidinonas.
DE10129725A1 (de) 2001-06-20 2003-01-02 Bayer Ag Kombinationstherapie substituierter Oxazolidinone
JP2005520782A (ja) * 2001-07-12 2005-07-14 ファルマシア・アンド・アップジョン・カンパニー・エルエルシー 向上した水溶解度を有するアミド含有化合物およびアミド含有化合物の水溶解度を向上させる方法
US7125568B2 (en) * 2001-08-23 2006-10-24 Sung Michael T Lipophilic drug compositions
WO2003062231A1 (en) * 2002-01-24 2003-07-31 Pharmacia & Upjohn Company Antimicrobial dihydrothiazine and dihydrothiopyran oxazolidinones
TW200302095A (en) * 2002-01-25 2003-08-01 Upjohn Co Oxazolidinone cotherapy
US7141588B2 (en) * 2002-02-25 2006-11-28 Pfizer, Inc. N-aryl-2-oxazolidinone-5-carboxamides and their derivatives
AR038536A1 (es) 2002-02-25 2005-01-19 Upjohn Co N-aril-2-oxazolidinona-5- carboxamidas y sus derivados
PL372661A1 (en) * 2002-03-29 2005-07-25 Pharmacia & Upjohn Company Llc. Parenteral, intravenous, and oral administration of oxazolidinones for treating diabetic foot infections
WO2003097640A1 (en) * 2002-05-22 2003-11-27 Orchid Chemicals & Pharmaceuticals Ltd. Oxazolidinone derivatives as antibacterial agents
TW200404069A (en) * 2002-06-28 2004-03-16 Upjohn Co Difluorothioacetamides of oxazolidinones with a glycoloylpiperazine substituent
TW200403240A (en) * 2002-06-28 2004-03-01 Upjohn Co Difluorothioacetamides of oxazolidinones as antibacterial agents
MXPA05001558A (es) 2002-08-12 2005-09-08 Pharmacia & Upjohn Co Llc N-aril-2-oxazolidinonas y sus derivados.
ATE344036T1 (de) 2002-11-21 2006-11-15 Pharmacia & Upjohn Co Llc N-(4-(piperazin-1-yl)-phenyl-2-oxazolidinon-5- carbonsäureamid-derivate und verwandte verbindungen als antibakterielle mittel
DE10300111A1 (de) 2003-01-07 2004-07-15 Bayer Healthcare Ag Verfahren zur Herstellung von 5-Chlor-N-({(5S)-2-oxo-3-[4-(3-oxo-4-morpholinyl)-phenyl]-1,3-oxazolidin-5-yl}-methyl)-2-thiophencarboxamid
CA2515311A1 (en) * 2003-02-07 2004-08-19 Warner-Lambert Company Llc Antibacterial agents
JP2006516989A (ja) * 2003-02-07 2006-07-13 ワーナー−ランバート・カンパニー、リミテッド、ライアビリティ、カンパニー 抗菌剤として使用するための二環式環によりｎ−置換されたオキサゾリジノン誘導体
US20040204463A1 (en) * 2003-04-01 2004-10-14 Harris Christina Renee N-aryl-2-oxazolidinone-5-carboxamides and their derivatives
AU2003223034A1 (en) * 2003-05-06 2004-11-26 Ranbaxy Laboratories Limited Oxazolidinone derivatives as antimicrobials
WO2004113329A1 (en) * 2003-06-20 2004-12-29 Orchid Chemicals And Pharmaceuticals Ltd. Oxazole derivatives as antibacterial agents
US7304050B2 (en) * 2003-09-16 2007-12-04 Pfizer Inc. Antibacterial agents
US7265140B2 (en) 2003-09-23 2007-09-04 Pfizer Inc Acyloxymethylcarbamate prodrugs of oxazolidinones
DE10355461A1 (de) 2003-11-27 2005-06-23 Bayer Healthcare Ag Verfahren zur Herstellung einer festen, oral applizierbaren pharmazeutischen Zusammensetzung
KR100854211B1 (ko) * 2003-12-18 2008-08-26 동아제약주식회사 신규한 옥사졸리디논 유도체, 그의 제조방법 및 이를유효성분으로 하는 항생제용 약학 조성물
WO2005082892A2 (en) * 2004-02-17 2005-09-09 Dr. Reddy's Laboratories Ltd. Triazole compounds as antibacterial agents and pharmaceutical compositions containing them
US20080262056A1 (en) * 2004-08-06 2008-10-23 Pfizer Inc Oxindole Oxazolidinones as Antibacterial Agents
EP1685841A1 (de) 2005-01-31 2006-08-02 Bayer Health Care Aktiengesellschaft Prophylaxe und Behandlung von thrombolischen Erkrankungen
EP1745784A1 (de) * 2005-06-27 2007-01-24 Ferrer Internacional, S.A. Oxazolidinonderivate und ihre Anwendung als Antibiotika
DE102005045518A1 (de) 2005-09-23 2007-03-29 Bayer Healthcare Ag 2-Aminoethoxyessigsäure-Derivate und ihre Verwendung
WO2007039132A1 (de) 2005-10-04 2007-04-12 Bayer Healthcare Ag Neue polymorphe form und die amorphe form von 5-chlor-n- ( { ( 5s ) -2-0x0-3-[4-( 3-oxo-4-morpholinyl) - phenyl] -1,3-oxazolidin-5-yl} -methyl) -2- thiophencarboxamid
DE102005047561A1 (de) 2005-10-04 2007-04-05 Bayer Healthcare Ag Feste, oral applizierbare pharmazeutische Darreichungsformen mit schneller Wirkstofffreisetzung
CN101460495B (zh) 2006-03-31 2013-08-14 财团法人乙卯研究所 具有杂环的化合物
US7875958B2 (en) * 2006-09-27 2011-01-25 Taiwan Semiconductor Manufacturing Company, Ltd. Quantum tunneling devices and circuits with lattice-mismatched semiconductor structures
WO2008143649A2 (en) * 2006-12-04 2008-11-27 Dr. Reddy's Laboratories Limited Novel oxazolidinone compounds as antiinfective agents
US20090279441A1 (en) * 2007-01-11 2009-11-12 Foundry Networks, Inc. Techniques for transmitting failure detection protocol packets
CL2008001003A1 (es) * 2007-04-11 2008-10-17 Actelion Pharmaceuticals Ltd Compuestos derivados de oxazolidinona; composicion farmaceutica que comprende a dichos compuestos; y su uso para preparar un medicamento para tratar una infeccion bacteriana.
EP2669283A1 (de) 2007-10-02 2013-12-04 Shionogi&Co., Ltd. Oxazolidinonderivat mit 7-gliedrigem Heteroring
KR101023174B1 (ko) * 2008-09-24 2011-03-18 주식회사 레고켐 바이오사이언스 사이클릭 아미독심 또는 사이클릭 아미드라존 기를 가지는 신규한 옥사졸리디논 유도체 및 이를 함유하는 의약 조성물
CN102224151A (zh) 2008-11-20 2011-10-19 万能药生物有限公司 新的抗微生物剂
CA2810478A1 (en) * 2010-09-07 2012-03-15 Symed Labs Limited Processes for the preparation of 4-{4-[5(s)-(aminomethyl)-2-oxo-1,3-oxazolidin-3-yl]phenyl}morpholin-3-one
AR093396A1 (es) * 2012-11-09 2015-06-03 Syngenta Participations Ag Derivados de dihidrotiofeno como compuestos insecticidas
EP3914587A4 (de) * 2019-01-18 2022-11-23 Merck Sharp & Dohme LLC Oxazolidinonverbindungen und verwendungen davon als antibakterielle mittel
KR20240021883A (ko) 2021-06-16 2024-02-19 셀진 코포레이션 신경변성 질환의 치료를 위한 카르복실산 기를 포함하는 아제티디닐 화합물
CN115724823B (zh) * 2021-08-27 2023-11-24 中国科学院大连化学物理研究所 一种制备二氢噻吩衍生物的方法

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1250538A (de) * 1969-03-18 1971-10-20
FR2356422A1 (fr) * 1976-03-01 1978-01-27 Delalande Sa Nouveaux hydroxymethyl-5 oxazolidinone-2, leur procede de preparation et leur application en therapeutique
FR2380780A2 (fr) * 1977-02-22 1978-09-15 Delalande Sa Application en therapeutique des hydroxymethyl-5 oxazolidinones-2, notamment comme antidepresseurs
FR2500450A1 (fr) * 1981-02-25 1982-08-27 Delalande Sa Nouveaux derives aminomethyl-5 oxazolidiniques, leur procede de preparation et leur application en therapeutique
JPS59118721A (ja) * 1982-12-25 1984-07-09 Nippon Zeon Co Ltd カルボキシル化合物の製造方法
US4705799A (en) * 1983-06-07 1987-11-10 E. I. Du Pont De Nemours And Company Aminomethyl oxooxazolidinyl benzenes useful as antibacterial agents
US4654428A (en) * 1984-12-18 1987-03-31 C. S. Kaseihin Company Inc. Process for preparation of silicon-containing isocyanate compounds
US4948801A (en) * 1988-07-29 1990-08-14 E. I. Du Pont De Nemours And Company Aminomethyloxooxazolidinyl arylbenzene derivatives useful as antibacterial agents
US5254577A (en) * 1988-07-29 1993-10-19 The Du Pont Merck Pharmaceutical Company Aminomethyloxooxazolidinyl arylbenzene derivatives useful as antibacterial agents
US5130316A (en) * 1988-07-29 1992-07-14 Du Pont Merck Pharmaceutical Company Aminomethyloxooxazlidinyl arylbenzene derivatives useful as antibacterial agents
EP0610265B1 (de) * 1991-11-01 1996-12-27 PHARMACIA & UPJOHN COMPANY Substituierte aryl- und heteroaryl-phenyloxazolidinone
SK283420B6 (sk) * 1992-05-08 2003-07-01 Pharmacia & Upjohn Company Antimikrobiálne oxazolidinóny obsahujúce substituované diazínové skupiny
US5668286A (en) * 1994-03-15 1997-09-16 Pharmacia & Upjohn Company Oxazolidinone derivatives and pharmaceutical compositions containing them
DE4425613A1 (de) * 1994-07-20 1996-01-25 Bayer Ag 5-gliedrige Heteroaryl-oxazolidinone
DE4425609A1 (de) * 1994-07-20 1996-01-25 Bayer Ag Benzofuranyl- und Benzothienyloxazolidinone
DE69616366T2 (de) * 1995-09-01 2002-07-04 Upjohn Co Phenyloxazolidinone mit einer c-c-bindung zu 4-8 gliedrigen heterocyclen
GB9702213D0 (en) * 1996-02-24 1997-03-26 Zeneca Ltd Chemical compounds
FI19992555A7 (fi) * 1997-05-30 1999-11-30 Upjohn Co Antibakteerisia oksatosolidinoniaineita, joilla on tiokarbonyylifunktionaalisuus
GB9717807D0 (en) * 1997-08-22 1997-10-29 Zeneca Ltd Chemical compounds
ES2194709T3 (es) * 1999-02-01 2003-12-01 Upjohn Co Procedimiento para preparar carbamatos de tetrahidrotiopiran-o-fluorados.
TW200403240A (en) * 2002-06-28 2004-03-01 Upjohn Co Difluorothioacetamides of oxazolidinones as antibacterial agents

Also Published As

Publication number Publication date
HUP9901979A2 (hu) 2000-02-28
FI980452L (fi) 1998-02-27
TW419468B (en) 2001-01-21
CZ49398A3 (cs) 1998-08-12
US6051716A (en) 2000-04-18
SK283487B6 (sk) 2003-08-05
ES2165516T3 (es) 2002-03-16
DK0856002T3 (da) 2002-02-11
EP0856002B1 (de) 2001-10-24
NO311520B1 (no) 2001-12-03
ZA966935B (en) 1998-02-16
HK1014946A1 (en) 1999-10-08
CN1072222C (zh) 2001-10-03
KR100463772B1 (ko) 2005-11-09
EP0856002A1 (de) 1998-08-05
PL325152A1 (en) 1998-07-06
NO980855D0 (no) 1998-02-27
RU2175324C2 (ru) 2001-10-27
MX9801578A (es) 1998-08-30
US20050054683A1 (en) 2005-03-10
US6313307B1 (en) 2001-11-06
DE69616366D1 (de) 2001-11-29
PL186524B1 (pl) 2004-01-30
BR9610474A (pt) 1999-03-02
US6358942B1 (en) 2002-03-19
NZ315469A (en) 2000-01-28
FI980452A7 (fi) 1998-02-27
SK19598A3 (en) 1998-11-04
NO980855L (no) 1998-04-30
UA52620C2 (uk) 2003-01-15
HUP9901979A3 (en) 2000-03-28
CN1197457A (zh) 1998-10-28
US6043266A (en) 2000-03-28
DE69616366T2 (de) 2002-07-04
US5968962A (en) 1999-10-19
JPH11512386A (ja) 1999-10-26
CA2228647A1 (en) 1997-03-13
PT856002E (pt) 2002-04-29
AU716493B2 (en) 2000-02-24
FI980452A0 (fi) 1998-02-27
WO1997009328A1 (en) 1997-03-13
KR19990044238A (ko) 1999-06-25
US6166056A (en) 2000-12-26
AU6718196A (en) 1997-03-27

Similar Documents

Publication Publication Date Title
DE69616366D1 (de) Phenyloxazolidinone mit einer c-c-bindung zu 4-8 gliedrigen heterocyclen
AU636012B2 (en) N-(4-piperidinyl)(dihydrobenzofuran or dihydro-2h-benzopyran )carboxamide derivatives
NO20011479D0 (no) Nye amidderivater, fremstilling derav og anvendelse som medikamenter og farmasøytiske sammensetninger inneholdende disse
HU9302497D0 (en) Method for producing new imidazole and pyrimidine derivatives
HU912610D0 (en) Process for producing benzofurane, benzothiophene, indole and indolysine derivatives and pharmaceutical preparatives containing said compounds
IL115572A0 (en) Novel substituted 4-(azanaphthoylamino)-piperidines salts of these and pharmaceutical compositions containing them
AU621771B2 (en) Novel 2-oxo-3,8-diazaspiro(4,5)decane derivatives, pharmaceutical compositions containing them and process for preparing the same

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee